Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

BACKGROUND: This study aimed to determine the influence of tocilizumab (TCZ) in modifying the clinical and laboratory features of macrophage activation syndrome (MAS) complicating systemic juvenile idiopathic arthritis (s-JIA). Furthermore, we assessed the performance of the 2016 MAS classification...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Rheumatol Online J
Main Authors: Shimizu, Masaki, Mizuta, Mao, Okamoto, Nami, Yasumi, Takahiro, Iwata, Naomi, Umebayashi, Hiroaki, Okura, Yuka, Kinjo, Noriko, Kubota, Tomohiro, Nakagishi, Yasuo, Nishimura, Kenichi, Mohri, Mariko, Yashiro, Masato, Yasumura, Junko, Wakiguchi, Hiroyuki, Mori, Masaaki
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6954608/
https://ncbi.nlm.nih.gov/pubmed/31924225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12969-020-0399-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados